Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ladik

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Klinische Wochenschrift|November 1, 1988
[Combination therapy with insulin/sulfonylurea in the long-term therapy of type II diabetes following "secondary failure"]N Lotz, W Bachmann, T Ladik, et al.
Diabetes Care|November 1, 1982
Crossover study with human insulin (recombinant DNA) in type I diabetic subjectsR Landgraf, S Kammerer, T Bock, et al.
Klinische Wochenschrift|July 1, 1987
Increased thromboplastic potential in diabetes: a multifactorial phenomenonM M Landgraf-Leurs, T Ladik, B Smolka, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Klinische Wochenschrift|November 1, 1988
[Combination therapy with insulin/sulfonylurea in the long-term therapy of type II diabetes following "secondary failure"]N Lotz, W Bachmann, T Ladik, et al.
Diabetes Care|November 1, 1982
Crossover study with human insulin (recombinant DNA) in type I diabetic subjectsR Landgraf, S Kammerer, T Bock, et al.
Klinische Wochenschrift|July 1, 1987
Increased thromboplastic potential in diabetes: a multifactorial phenomenonM M Landgraf-Leurs, T Ladik, B Smolka, et al.
Pageof 1